MedTrace Logo

The Swedish Essential Tremor (SWEET) Trial

NCT03832712 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-05-25

No results posted yet for this study

Summary

To evaluate the effect of deep brain stimulation (DBS) vs best medical treatment in essential tremor (ET) in a randomized, single-blinded controlled trial.

Conditions

Interventions

PROCEDURE

Deep Brain Stimulation

Surgical implantation of intracranial leads for deep brain stimulation, extension cables and implantable pulse generator

DRUG

Best Medical Treatment

Unselective β-blockers such as Propanolol

Sponsors & Collaborators

  • Umeå University

    collaborator OTHER

  • Uppsala University

    collaborator OTHER

  • Lund University

    collaborator OTHER

  • University Hospital, Linkoeping

    collaborator OTHER

  • Göteborg University

    collaborator OTHER

  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Patric Blomstedt, PhD · Umeå Universitet

  • Anders Fytagoridis, PhD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-30
Primary Completion
2026-01-30
Completion
2027-01-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03832712 on ClinicalTrials.gov